Shanghai MicroPort EP MedTech Co., Ltd. (SHA:688351)
China · Delayed Price · Currency is CNY 17.06
+0.09 (0.53%)
At close: Sep 30, 2026
SHA:688351 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,028 | 10,894 | 8,960 | 12,071 | 12,457 | - | |
Market Cap Growth | -22.24% | 21.59% | -25.77% | -3.10% | - | - |
Enterprise Value | 6,795 | 9,609 | 7,602 | 10,714 | 10,999 | - |
Last Close Price | 17.06 | 23.13 | 19.02 | 25.63 | 26.45 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 137.27 | 213.27 | 172.08 | 2121.98 | 4054.86 | - |
Forward PE | 114.89 | 122.29 | 138.88 | 296.58 | - | - |
PS Ratio | 15.56 | 23.45 | 21.69 | 36.67 | 47.85 | - |
PB Ratio | 4.43 | 6.05 | 5.14 | 7.16 | 7.43 | - |
P/TBV Ratio | 4.66 | 6.33 | 5.37 | 7.55 | 7.62 | - |
P/FCF Ratio | - | - | 381.03 | - | - | - |
P/OCF Ratio | 289.14 | 119.85 | 133.07 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 13.17 | 20.69 | 18.40 | 32.55 | 42.25 | - |
EV/EBITDA Ratio | 147.02 | 186.46 | 230.09 | - | - | - |
EV/EBIT Ratio | - | 458.06 | 1734.88 | - | - | - |
EV/FCF Ratio | - | - | 323.27 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 0.10 | 0.08 | 0.40 | - | 87.30 | - |
Debt / FCF Ratio | - | - | 0.71 | - | - | - |
Net Debt / Equity Ratio | -0.68 | -0.72 | -0.77 | -0.77 | -0.86 | -0.71 |
Net Debt / EBITDA Ratio | -29.32 | -25.20 | -40.61 | 85.82 | 390.32 | 19.84 |
Net Debt / FCF Ratio | 51.54 | 41.45 | -57.06 | 16.35 | 34.78 | 26.07 |
Asset Turnover | 0.26 | 0.24 | 0.22 | 0.18 | 0.21 | 0.29 |
Inventory Turnover | 1.37 | 1.38 | 1.39 | 1.15 | 1.23 | 1.33 |
Quick Ratio | 7.17 | 8.70 | 13.34 | 14.41 | 22.70 | 9.79 |
Current Ratio | 8.36 | 9.78 | 14.57 | 15.75 | 24.12 | 10.89 |
Return on Equity (ROE) | 3.26% | 2.88% | 3.04% | 0.34% | 0.27% | -2.05% |
Return on Assets (ROA) | 0.29% | 0.68% | 0.15% | -1.26% | -0.86% | -3.07% |
Return on Invested Capital (ROIC) | 1.67% | 4.62% | 1.12% | -11.81% | -8.27% | -20.90% |
Return on Capital Employed (ROCE) | 0.50% | 1.10% | 0.20% | -2.10% | -1.00% | -5.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.73% | 0.47% | 0.58% | 0.05% | 0.03% | - |
FCF Yield | -0.30% | -0.29% | 0.26% | -0.66% | -0.33% | - |
Dividend Yield | 0.12% | 0.09% | - | - | - | - |
Buyback Yield / Dilution | 0.10% | -0.00% | -0.14% | -11.71% | -5.08% | -4.62% |
Total Shareholder Return | 0.23% | 0.09% | -0.14% | -11.71% | -5.08% | -4.62% |